Veterinary Medicine Information website

Nobilis Ma5+Clone 30 vakcina A.U.V.

Authorised
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Download as PDF

Product identification

Medicine name:
Nobilis Ma5+Clone 30 vakcina A.U.V.
Active substance:
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Target species:
  • Chicken (hen)
Route of administration:
  • In drinking water/milk use
  • Intraocular use
  • Nasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    3.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    3.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Oral lyophilisate
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Intraocular use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Nasal use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: